Cargando…
A Multi-Target and Multi-Channel Mechanism of Action for Jiawei Yinhuo Tang in the Treatment of Social Communication Disorders in Autism: Network Pharmacology and Molecular Docking Studies
BACKGROUND: Autism spectrum disorder (ASD) is a highly heterogeneous neurodevelopmental disorder with complex pathogenesis. Currently, the pathogenesis of ASD is not fully understood. Moreover, current treatments do not effectively alleviate the primary symptoms of ASD social disorder (SCDA). Jiawei...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846994/ https://www.ncbi.nlm.nih.gov/pubmed/35178102 http://dx.doi.org/10.1155/2022/4093138 |
_version_ | 1784651954958368768 |
---|---|
author | Linlin, Zhang Ciai, Lai Yanhong, Su Huizhong, Gan Yongchun, Li Zhen, Yang Shan, Xu Fengying, Gong Ying, Lv Jingjun, Li Qin, Fan |
author_facet | Linlin, Zhang Ciai, Lai Yanhong, Su Huizhong, Gan Yongchun, Li Zhen, Yang Shan, Xu Fengying, Gong Ying, Lv Jingjun, Li Qin, Fan |
author_sort | Linlin, Zhang |
collection | PubMed |
description | BACKGROUND: Autism spectrum disorder (ASD) is a highly heterogeneous neurodevelopmental disorder with complex pathogenesis. Currently, the pathogenesis of ASD is not fully understood. Moreover, current treatments do not effectively alleviate the primary symptoms of ASD social disorder (SCDA). Jiawei Yinhuo Tang (JWYHT) is an improved version of the classic prescription Yinhuo Tang. Although this medication has been shown to improve social behavior in ASD patients, the mechanism by which it works remains unknown. METHODS: In this study, network pharmacology bioinformatics analysis was used to identify the key targets, biological functions, and signal pathways of JWYHT in SCDA. Then, molecular docking and molecular dynamic simulation were used to validate the activity and stability of the active ingredient and the target protein during the binding process. RESULTS: The analysis identified 157 key targets and 9 core targets of JWYHT (including proto-oncogene (FOS), caspase 3 (CASP3), mitogen-activated protein kinase-3 (MAPK3), interleukin-6 (IL6), mitogen-activated protein kinase-1 (MAPK1), tumor necrosis factor (TNF), mitogen-activated protein kinase-8 (MAPK8), AKT serine/threonine kinase 1 (AKT1), and 5-hydroxytryptamine receptor 1B (5HT1B)) in SCDA. In addition, the Kyoto Encyclopedia of Gene and Genome results, as well as the staggering network analyses, revealed 20 biological processes and 20 signal pathways targeted by JWYHT in SCDA. Finally, molecular docking analysis was used to determine the binding activity of the main active components of JWYHT to the key targets. The binding activity and stability of methyl arachidonate and MAPK8 were demonstrated using molecular dynamics simulation. CONCLUSION: This study demonstrates that JWYHT regulates neuronal development, synaptic transmission, intestinal and cerebral inflammatory response, and other processes in SCDA. |
format | Online Article Text |
id | pubmed-8846994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-88469942022-02-16 A Multi-Target and Multi-Channel Mechanism of Action for Jiawei Yinhuo Tang in the Treatment of Social Communication Disorders in Autism: Network Pharmacology and Molecular Docking Studies Linlin, Zhang Ciai, Lai Yanhong, Su Huizhong, Gan Yongchun, Li Zhen, Yang Shan, Xu Fengying, Gong Ying, Lv Jingjun, Li Qin, Fan Evid Based Complement Alternat Med Research Article BACKGROUND: Autism spectrum disorder (ASD) is a highly heterogeneous neurodevelopmental disorder with complex pathogenesis. Currently, the pathogenesis of ASD is not fully understood. Moreover, current treatments do not effectively alleviate the primary symptoms of ASD social disorder (SCDA). Jiawei Yinhuo Tang (JWYHT) is an improved version of the classic prescription Yinhuo Tang. Although this medication has been shown to improve social behavior in ASD patients, the mechanism by which it works remains unknown. METHODS: In this study, network pharmacology bioinformatics analysis was used to identify the key targets, biological functions, and signal pathways of JWYHT in SCDA. Then, molecular docking and molecular dynamic simulation were used to validate the activity and stability of the active ingredient and the target protein during the binding process. RESULTS: The analysis identified 157 key targets and 9 core targets of JWYHT (including proto-oncogene (FOS), caspase 3 (CASP3), mitogen-activated protein kinase-3 (MAPK3), interleukin-6 (IL6), mitogen-activated protein kinase-1 (MAPK1), tumor necrosis factor (TNF), mitogen-activated protein kinase-8 (MAPK8), AKT serine/threonine kinase 1 (AKT1), and 5-hydroxytryptamine receptor 1B (5HT1B)) in SCDA. In addition, the Kyoto Encyclopedia of Gene and Genome results, as well as the staggering network analyses, revealed 20 biological processes and 20 signal pathways targeted by JWYHT in SCDA. Finally, molecular docking analysis was used to determine the binding activity of the main active components of JWYHT to the key targets. The binding activity and stability of methyl arachidonate and MAPK8 were demonstrated using molecular dynamics simulation. CONCLUSION: This study demonstrates that JWYHT regulates neuronal development, synaptic transmission, intestinal and cerebral inflammatory response, and other processes in SCDA. Hindawi 2022-02-08 /pmc/articles/PMC8846994/ /pubmed/35178102 http://dx.doi.org/10.1155/2022/4093138 Text en Copyright © 2022 Zhang Linlin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Linlin, Zhang Ciai, Lai Yanhong, Su Huizhong, Gan Yongchun, Li Zhen, Yang Shan, Xu Fengying, Gong Ying, Lv Jingjun, Li Qin, Fan A Multi-Target and Multi-Channel Mechanism of Action for Jiawei Yinhuo Tang in the Treatment of Social Communication Disorders in Autism: Network Pharmacology and Molecular Docking Studies |
title | A Multi-Target and Multi-Channel Mechanism of Action for Jiawei Yinhuo Tang in the Treatment of Social Communication Disorders in Autism: Network Pharmacology and Molecular Docking Studies |
title_full | A Multi-Target and Multi-Channel Mechanism of Action for Jiawei Yinhuo Tang in the Treatment of Social Communication Disorders in Autism: Network Pharmacology and Molecular Docking Studies |
title_fullStr | A Multi-Target and Multi-Channel Mechanism of Action for Jiawei Yinhuo Tang in the Treatment of Social Communication Disorders in Autism: Network Pharmacology and Molecular Docking Studies |
title_full_unstemmed | A Multi-Target and Multi-Channel Mechanism of Action for Jiawei Yinhuo Tang in the Treatment of Social Communication Disorders in Autism: Network Pharmacology and Molecular Docking Studies |
title_short | A Multi-Target and Multi-Channel Mechanism of Action for Jiawei Yinhuo Tang in the Treatment of Social Communication Disorders in Autism: Network Pharmacology and Molecular Docking Studies |
title_sort | multi-target and multi-channel mechanism of action for jiawei yinhuo tang in the treatment of social communication disorders in autism: network pharmacology and molecular docking studies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846994/ https://www.ncbi.nlm.nih.gov/pubmed/35178102 http://dx.doi.org/10.1155/2022/4093138 |
work_keys_str_mv | AT linlinzhang amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT ciailai amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT yanhongsu amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT huizhonggan amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT yongchunli amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT zhenyang amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT shanxu amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT fengyinggong amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT yinglv amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT jingjunli amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT qinfan amultitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT linlinzhang multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT ciailai multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT yanhongsu multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT huizhonggan multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT yongchunli multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT zhenyang multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT shanxu multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT fengyinggong multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT yinglv multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT jingjunli multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies AT qinfan multitargetandmultichannelmechanismofactionforjiaweiyinhuotanginthetreatmentofsocialcommunicationdisordersinautismnetworkpharmacologyandmoleculardockingstudies |